Pharmya

  • Home
  • About us
  • Services
    • Pharmacovigilance Systems
    • Operational Pharmacovigilance Activities
    • EU QPPV & Local QPPV services
    • Pharmacovigilance Audits and Training
  • News
  • Careers
  • Contact us
  • English
  • Français
  • Español
You are here: Pharmya > Articles by: Ryan McArthur
FAQ for the webinar on the new European legislation on clinical trials for medicinal products
2023 May May 30

FAQ for the webinar on the new European legislation on clinical trials for medicinal products

https://ansm.sante.fr/documents/reference/reglementation-relative-aux-essais-ou-investigations-cliniques/faq-du-webinaire-dedie-au-nouveau-reglement-europeen-des-essais-cliniques-de-medicaments

Read more
EMA: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 10 – 12 May 2023
2023 May May 25

EMA: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 10 – 12 May 2023

https://www.ema.europa.eu/en/news/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-10-12-may-2023

Read more
EMA – Annual Report 2022
2023 May May 23

EMA – Annual Report 2022

https://www.ema.europa.eu/en/news/ema-annual-report-2022-published

Read more
EU – Quick guide on Clinical trials regulation
2023 May May 15

EU – Quick guide on Clinical trials regulation

Read more
EMA: Minutes of PRAC meeting on 09 Jan to 12 Jan 2023
2023 May May 11

EMA: Minutes of PRAC meeting on 09 Jan to 12 Jan 2023

Read more
Reporting a quality defect on a medicine
2023 May May 09

Reporting a quality defect on a medicine

Read more
Frequently Asked Questions: Revision of the Pharmaceutical legislation
2023 May May 04

Frequently Asked Questions: Revision of the Pharmaceutical legislation

Read more
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 24 – 26 April 2023
2023 April Apr 28

Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 24 – 26 April 2023

Read more
data.ansm: an online platform to find out more about adverse drug reactions and product shortages
2023 April Apr 24

data.ansm: an online platform to find out more about adverse drug reactions and product shortages

https://ansm.sante.fr/actualites/data-ansm-une-plateforme-en-ligne-pour-en-savoir-plus-sur-les-effets-indesirables-des-medicaments-et-les-ruptures-de-stock

Read more
Meeting Highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) meeting 11-14 April 2023
2023 April Apr 21

Meeting Highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) meeting 11-14 April 2023

Read more
  • « Previous

Pharmya – Pharmacovigilance

PHARMYA is a French based company, dedicated to providing Pharmacovigilance services. Its mission is to support the pharmaceutical industry, biotechnology companies, research centers and their service providers in their efforts to comply with international Pharmacovigilance regulations.

Contact

  • PHARMYA
  • 315 Av. Saint Sauveur du Pin
  • 34980 Saint Clément de Rivière (Montpellier), France
  • Phone: +33 411 93 21 10
  • Email: info@pharmya.com
  • Website: www.pharmya.com

News

  • FAQ for the webinar on the new European legislation on clinical trials for medicinal products
  • EMA: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 10 – 12 May 2023
  • EMA – Annual Report 2022
Copyright © 2018 - Pharmya - Legal terms - Quality Policy